Oxynorm Dispersa

Active Ingredient:: Oxycodone Hydrochloride
Origin:: EU

Oxynorm Dispersa (Oxycodone Hydrochloride)

International sale not permitted. Listed for the domestic market and B2B only.

Oxycodone Hydrochloride, the active ingredient in Oxynorm Dispersa, is an opioid analgesic presented as a strength/form for oral use. It is indicated for the management of moderate to severe pain in adult patients. GNH India supplies Oxynorm Dispersa as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH India supplies Oxynorm Dispersa as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Ethypharm

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Oxynorm Dispersa is an opioid analgesic that acts on the central nervous system to relieve pain.

Acute postoperative pain: provides effective relief following surgical procedures.
Cancer‑related pain: helps control moderate to severe pain associated with malignancies.
Chronic non‑cancer pain: used when other analgesics are insufficient for conditions such as severe osteoarthritis.

How It Works

Oxycodone hydrochloride binds to µ‑opioid receptors in the brain and spinal cord, activating inhibitory G‑protein pathways that reduce neuronal excitability and diminish the transmission of nociceptive signals, thereby producing analgesia.

Side Effects

Adverse reactions may vary in frequency and severity.

Common Side Effects

Constipation: reduced gastrointestinal motility.
Nausea: mild to moderate upset stomach.
Drowsiness: increased sleepiness or sedation.
Dry mouth: decreased salivary flow.
Dizziness: light‑headed sensation.
Itching: mild pruritus.

Serious or Rare Side Effects

Respiratory depression: slowed or shallow breathing.
Severe hypotension: marked drop in blood pressure.
Dependence or addiction: potential for misuse.
Seizures: rare convulsive episodes.
Anaphylaxis: acute allergic reaction.
Adrenal insufficiency: impaired cortisol production.

Precautions & Warnings

When prescribing Oxynorm Dispersa, clinicians should consider several safety measures.

Assess pain severity: ensure opioid therapy is appropriate for the level of pain.
Evaluate respiratory function: monitor patients with existing respiratory disorders.
Review medication history: avoid concurrent use with other central nervous system depressants.
Counsel on dependence risk: educate patients about signs of misuse.
Monitor renal and hepatic function: adjust use in impaired organ function.
Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Oxynorm Dispersa can interact with a range of medicines, requiring careful management.

Major Interactions (Avoid)

Other opioids: combined use can cause profound respiratory depression.
Benzodiazepines: concurrent use increases sedation and respiratory risk.
CNS depressants: additive effects may lead to excessive drowsiness.

Moderate Interactions (Monitor Closely)

MAO inhibitors: may precipitate hypertensive crisis.
Antidepressants (SSRIs, SNRIs): can increase serotonin levels and risk serotonin syndrome.
Antihistamines: may enhance sedative effects.

Frequently Asked Questions

Oxynorm Dispersa contains oxycodone hydrochloride, an opioid analgesic used to treat moderate to severe pain, including postoperative pain, cancer‑related pain, and chronic non‑cancer pain when other analgesics are insufficient.

Oxycodone hydrochloride binds to µ‑opioid receptors in the central nervous system, activating inhibitory pathways that lower neuronal excitability and block the transmission of pain signals, resulting in analgesia.

The dose of Oxynorm Dispersa is individualized by the prescribing clinician based on the patient’s pain severity, prior opioid exposure, age, renal and hepatic function, and other clinical factors.

Oxycodone crosses the placenta and is excreted in breast milk; therefore, it is generally contraindicated during pregnancy and lactation unless the potential benefit justifies the risk and it is prescribed by a specialist.

To order, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and necessary import documentation.

Oxynorm Dispersa provides potent µ‑opioid receptor activation similar to other strong opioids such as morphine or hydromorphone, but formulation differences may affect onset, duration and dosing flexibility, influencing clinician choice based on patient needs.

Store Oxynorm Dispersa at temperatures below 25 °C in its original container, protected from moisture, heat and direct sunlight. Keep out of reach of children and unauthorized persons.

Oxynorm Dispersa is intended for oral administration. The tablet or capsule should be swallowed whole with water unless the prescribing information specifies an alternative method such as dispersing in a small amount of liquid.

Serious risks include respiratory depression, severe hypotension, dependence or addiction, and rare events such as seizures or anaphylaxis. Patients should be monitored closely, especially during dose initiation and when combined with other depressant drugs.

Oxynorm Dispersa is contraindicated in individuals with known hypersensitivity to oxycodone or any formulation component, in patients with severe respiratory depression, acute or severe asthma, and in those taking monoamine oxidase inhibitors within 14 days.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 11 Oct 2026

Disclaimer

International sale not permitted. Listed for the domestic market and B2B only.

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.